-+ 0.00%
-+ 0.00%
-+ 0.00%

Kiora Pharmaceuticals Q4 EPS $(1.60) Misses $(0.67) Estimate

Benzinga·03/25/2026 22:17:45
Listen to the news
Kiora Pharmaceuticals (NASDAQ:KPRX) reported quarterly losses of $(1.60) per share which missed the analyst consensus estimate of $(0.67) by 138.81 percent. This is a 61.62 percent decrease over losses of $(0.99) per share from the same period last year.